Get started
Author

Sanjiv Kapoor

Observed names: Kapoor, Sanjiv, S Kapoor, S. Kapoor, SANJIV KAPOOR, Sanjiv KAPOOR
Observed institution: Indian Spinal Injuries Centre
ORCID: 0009-0008-1962-926X
Observed ORCID: 0009-0008-1962-926X
OpenAlex ID: A5080574571
Low‐dose and high‐dose methotrexate are two different drugs in practical terms
2010 · Anand N. MALAVIYA, Amit SHARMA, et al. · International Journal of Rheumatic Diseases · 58
Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report
2009 · ANAND N. MALAVIYA, SANJIV KAPOOR, et al. · The Journal of Rheumatology · 43
PDF
Tuberculosis and biologics in rheumatology: A special situation
2017 · Rohini Handa, Sundeep Upadhyaya, et al. · International Journal of Rheumatic Diseases · 31
Acute abdomen in SLE
2010 · Anand N. MALAVIYA, Amit SHARMA, et al. · International Journal of Rheumatic Diseases · 22
Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease‐modifying anti‐rheumatic drugs in India, a high‐burden TB country: The importance of Mantoux and Quantiferon‐ TB Gold tests
2018 · Anand N. Malaviya, Vishal K. Aggarwal, et al. · International Journal of Rheumatic Diseases · 21
Acute inflammatory ankle arthritis in northern India--Löfgren's syndrome or Poncet's disease?
2011 · Shriram Garg, Anand N Malaviya, et al. · PubMed · 19
A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
2007 · A N Malaviya, S Kapoor, et al. · PubMed · 19
Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
2019 · Sanjiv Kapoor, Viswanath V. Kaushik, et al. · ACR Open Rheumatology · 15
PDF
Real Life Experience of a Screening Strategy for Latent Tuberculosis before Treatment with Biologicals in Indian Patients with Rheumatic Diseases
2018 · Anand N Malaviya, Ravita Thakaran, et al. · Indian Journal of Rheumatology · 15
PDF
Recommended Screening Strategy for Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — Followup Report
2009 · ANAND N. MALAVIYA, SANJIV KAPOOR, et al. · The Journal of Rheumatology · 8
PDF
Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
2019 · Sanjiv Kapoor, Viswanath V. Kaushik, et al. · Rheumatology and Therapy · 7
PDF
Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
2010 · Anand Narayan Malaviya, Sujata Sawhney, et al. · PubMed · 6
Cost-effective use of investigations in developing countries
2014 · Anand N. Malaviya, Sanjiv Kapoor · Best Practice & Research Clinical Rheumatology · 3
Tuberculin Skin Test for the Screening of Latent Tuberculosis Infection Before Starting Treatment with Tumour Necrosis Factor- α Inhibitors In Systemic Immunoinflammatory Rheumatic Diseases in India - A High Burden Tuberculosis Region of the World
2018 · Anand N Malaviya, Vishal K Aggarwal, et al. · Journal of Rheumatology and Arthritic Diseases · 2
PDF
Role of Myositis-specific Autoantibodies in Personalized Therapy
2018 · Anand N Malaviya, Sanjiv Kapoor · Indian Journal of Rheumatology · 2
Switching from Other Biologics to ZRC3197 (Adalimumab Biosimilar) in Patients with Spondyloarthropathy: A Prospective Evaluation from Real-Life Clinical Practice.
2017 · Sanjiv Kapoor · PubMed · 2
OP0192-HPR Teaching Methotrexate Self-Injection Technique To The Patients in A Routine Rheumatology Out-Patient Clinic: Factors Favouring or Countering Acceptability
2016 · R. Rawat, S.S. Baghel, et al. · Annals of the Rheumatic Diseases · 2
P58 Efficacy and safety of a biosimilar-rituximab (‘Reditux’®) in rheumatoid arthritis (RA)
2009 · Roopa Rawat, Sanjiv Kapoor, et al. · Indian Journal of Rheumatology · 2
Simplifying Pneumococcal Vaccination in Autoimmune Rheumatic Diseases: The Impact of Prevnar 20
2026 · Anand N. Malaviya, Prassan Deep Rath, et al. · Indian Journal of Rheumatology · 1
Atherosclerotic Cardiovascular Disease (ASCVD) in Rheumatoid Arthritis (RA)—Indian Perspective
2024 · Anand N. Malaviya, Sanjiv Kapoor · Indian Journal of Rheumatology · 1
Gout in Premenopausal Women and in Pregnancy - A Case-Based Review
2020 · Lubna Khurshid, Suraj Chaudhari, et al. · Indian Journal of Rheumatology · 1
Recent Advances in Idiopathic Inflammatory Myopathies (IIM) - Rapid Discoveries of Myositis-specific Antibodies (MSAS) and Myositis-Associated Antibodies (MAAS) - Moving Towards 'Precision Medicine'.
2019 · Anand N Malaviya, Shubha Bhalla, et al. · PubMed · 1
AB1479-HPR Multifaceted intervention to improve medication understanding and compliance among patients with autoimmune inflammatory rheumatic diseases
2018 · R Thakran, S.S. Baghel, et al. · Annals of the Rheumatic Diseases · 1
PDF
O3 Success of an earlier recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumour necrosis factor-α inhibitors in India—a follow-up report
2009 · Anand N Malaviya, Sanjiv Kapoor, et al. · Indian Journal of Rheumatology · 1
Screening for Tuberculosis Infection in Rheumatology Practice: An Update
2026 · Anand N. Malaviya, Niti Kedia, et al. · Indian Journal of Rheumatology
Works count: 41
Citation count: 283
H-index: 9
I10-index: 9
Year
Topic
Type